IL1 inhibitor en es it fr

IL1 inhibitor Brand names, IL1 inhibitor Analogs

IL1 inhibitor Brand Names Mixture

  • No information avaliable

IL1 inhibitor Chemical_Formula


IL1 inhibitor RX_link

IL1 inhibitor fda sheet

IL1 inhibitor msds (material safety sheet)

IL1 inhibitor Synthesis Reference

No information avaliable

IL1 inhibitor Molecular Weight


IL1 inhibitor Melting Point

No information avaliable

IL1 inhibitor H2O Solubility

No information avaliable

IL1 inhibitor State


IL1 inhibitor LogP


IL1 inhibitor Dosage Forms


IL1 inhibitor Indication

For treatment of adult rheumatoid arthritis

IL1 inhibitor Pharmacology

Used to treat rheumatoid arthritis, Kineret blocks the biologic activity of IL-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.1 IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses. Patients with rheumatoid arthritis have elevated levels of IL-1. The levels of the naturally occurring IL-1Ra in synovium and synovial fluid from rheumatoid arthritis (RA) patients are not sufficient to compete with the elevated amount of locally produced IL-1. Increasing the levels of IL-1Ra by artificial means reduces the negative effects (cartilage degradation, bone resorption) of IL-1.

IL1 inhibitor Absorption

No information avaliable

IL1 inhibitor side effects and Toxicity

No information avaliable

IL1 inhibitor Patient Information


IL1 inhibitor Organisms Affected

Humans and other mammals